Development of fibrin-specific nuclear probe to reduce lvad adverse events
Ended Project Grant Awarded Last action
- Award ID
- R42HL139342
- Recipient
-
Capella Imaging Inc. UEI HNNMF98N2AF8
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,648,725
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- St. Louis, MO 63108, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $728,200 | |
| Amendment | $0 | |
| Amendment | $768,622 | |
| Amendment | $0 | |
| Original award | $151,903 |
Quick answers
Who received award R42HL139342?
R42HL139342 was awarded to Capella Imaging Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2017.
How much is award R42HL139342 worth?
$1,648,725 has been obligated on R42HL139342.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award